查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1197818

眼科超声市场 - 增长、趋势、COVID-19 影响和预测 (2023-28)

Ophthalmic Ultrasound Systems Market - Growth, Trends, and Forecasts (2023-28)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，眼科超声系统市场预计将以 7% 的复合年增长率增长。

大流行影响了市场，各种研究提供了这种见解。 例如，根据 Parul C Gupta 等人在 2021 年 12 月出版的《印度眼科杂誌》上发表的一项研究，接受调查的诊所计划进行 7,500 次白内障手术，但由于大流行，只有 2,500 次。他说他不能。 数据表明，在 COVID-19 大流行期间，白内障手术显着减少。 然而，随着长时间工作导致屏幕时间增加，眼病是全球最常报告的问题之一，导致眼病患病率增加，研究期间的调查可能会提振市场生长。 例如，根据 Jason M. Nagata 等人发表的一项研究，屏幕时间增加会对青少年的身心健康产生负面影响。 因此，预计 COVID-19 的长期影响将对所研究的市场产生有利影响。

全球近视（nearsightedness）、远视（hyperopia）、散光（distorted vision）和老花眼等光学损伤负担日益加重，将在研究预测期内推动超声眼科设备市场的增长。预计一个主要的驱动力。 例如，根据世界卫生组织 (WHO) 2021 年 10 月更新，全球约有 22 亿人患有近视或远视，其中约有 10 亿人的视力障碍是可以预防的，或者尚未得到解决。 此外，据世界卫生组织称，未经治疗的老花眼估计影响全球约 8.26 亿人。 根据上述数据，未矫正的屈光不正、白内障、年龄相关性黄斑变性和青光眼是全球视力损害和失明的主要原因，视力下降的发生与年龄无关。不过，据说大多数都超过了50岁。 因此，上述描述是被调查市场增长的动力，由于眼科超声设备用于诊断此类眼科疾病，全球眼科疾病的负担越来越重。表明

但是，其他诊断工具的进步和采用以及严格的政府法规预计会阻碍市场增长。

眼科超声设备市场趋势

B-Scan 占有重要的市场份额

B 扫描或亮度扫描提供眼球的二维横截面。 适用于闭合的眼睑外侧。 当眼睛检查困难时，通常使用 B 扫描。 B 扫描因这些优势而在全球范围内广泛使用，并且随着公司开发新颖且技术先进的 B 扫描，需求也在增长。 疾病增多等因素加上市场参与者的举措预计将推动市场增长。 例如，2022 年 2 月发表在国家医学图书馆的一项研究表明，在过去 20 年中，眼部和附件疾病的住院率增加了 73.8%。 因此，高住院率增加了对诊断和外科眼科护理设备的需求，从而推动了市场的发展。 此外，上述调查报告显示，视障人士多为年长者，年龄在50岁以上。 这个年龄段的人中有 80% 以上患有眼疾。 因此，预计老年人口负担的增加将增加该国眼科疾病的患病率，从而推动该领域的增长。 糖尿病视网膜病变的流行是市场增长的主要驱动力之一。 根据美国眼科学会最近发布的流行病学统计数据，目前全球有 3.87 亿糖尿病患者，预计到 2035 年这一数字将上升到 5.92 亿。 此外，糖尿病性视网膜病变影响全世界 9300 万人。 糖尿病视网膜病变在 1 型糖尿病患者中的患病率为 77.3%，在 2 型糖尿病患者中的患病率为 25.1%，其中 25% 至 30% 预计会发展为威胁视力的糖尿病性黄斑水肿。 5% 到 8% 的糖尿病视网膜病变患者需要激光治疗。 多达 5% 的人可能需要玻璃体切除术。 眼底 B 型超声检查用于检测和评估预测视力结果的糖尿病性视网膜病变并发症。

扩张等各种举措是细分市场增长的重要因素。 2022 年 6 月，Lumivad Medical 通过在印度设立子公司扩大了其在印度的业务。 该公司提供多种眼科超声产品，如 ABSOLU、COMPACT TOUCH 和 AXIALIS。 预计这些努力将扩大印度市场，从而推动整个全球市场的增长。

随着各种眼病发病率的增加，预计未来几年对B-Scan眼底超声系统的需求将会增加。

北美主导市场，预计在预测期内将继续保持这一势头

高可支配收入、高意识、老年人口增加和眼病流行等因素正在推动北美地区研究市场的增长。 各种已发表的研究文章提供了对失明和其他眼病流行率的见解。 例如，一篇引用克利夫兰诊所发表于 2022 年 1 月的文章指出，美国超过 340 万年龄在 40 岁以上的人符合法定失明或视力矫正的定义。 尚未诊断的目标疾病的这种增加也有望推动市场增长。 同样，安大略省验光师协会2021年7月发表的一篇文章称，随着加拿大人口老龄化，矫正视力的人数将会增加，影响加拿大的医疗保健系统和经济。 根据该报告，有 120 万加拿大人患有视力丧失，仅安大略省就有 466,000 人。 上述消息来源还指出，超过 800 万加拿大人，近 310 万在安大略省，患有四大眼科疾病之一（年龄相关性黄斑变性、青光眼、糖尿病性视网膜病变、白内障）和视力丧失。它还提到生活在存在风险的状态 眼科疾病的这种增加预计将增加对用于早期诊断的眼科超声设备的需求并推动市场增长。

眼科超声市场竞争对手分析

眼科超声系统市场适度细分。 世界领先的公司製造了大部分眼科超声系统。 拥有更多研究资金和更好的分销系统的市场领导者正在市场中站稳脚跟。 市场上的主要参与者是 Appasamy Associates、DGH Technology Inc.、Micro Medical Devices、NIDEK、Optos PLC（Nikon Corporation）、Quantel Medical（Ellex Medical Lasers Ltd）、Lumibird Medical（Quantel Medical）、AMETEK（Reichert Inc）和 Sonomed Escalon。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第1章介绍

  • 研究假设和市场定义
  • 调查范围

第2章研究方法论

第 3 章执行摘要

第4章市场动态

  • 市场概览
  • 市场驱动力
    • 眼病患病率增加
    • 新眼科技术的出现
    • 政府公共卫生意识计划的增加
  • 市场製约因素
    • 其他诊断工具的进步和采用率的提高
    • 严格的政府法规
  • 波特的五力分析
    • 供应商的议价能力
    • 买家和消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模：100 万美元）

  • 按产品分类
    • A扫描
    • B超扫描
    • 组合扫描
    • 测厚仪
    • 超声生物显微镜 (UBM)
  • 按方式
    • 便携式
    • 独立的
  • 最终用户
    • 医院
    • 眼科诊所
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章竞争格局

  • 公司简介
    • AMETEK（Reichert Inc.）
    • Appasamy Associates
    • Carl Zeiss Meditec AG
    • Clarion Medical Technologies
    • DGH Technology Inc.
    • Halma plc
    • Lumibird Medical（Quantel Medical）
    • MEDA Co., Ltd（Tianjin Pharmaceutical Holdings Ltd）
    • Micro Medical Devices
    • NIDEK CO., LTD.
    • Optos PLC（Nikon Corporation）
    • Sonomed Escalon

第7章 市场机会与今后动向

简介目录
Product Code: 64423

The ophthalmic Ultrasound Systems Market is poised to grow at a CAGR of 7% during the forecast period.

The pandemic had an effect on the market and various research studies provide insight into that. For instance, according to a research study published by Parul C Gupta et. al., in the December 2021 edition of the Indian Journal of Ophthalmology, the studied clinic was expected to perform 7,500 cataract procedures, but due to the pandemic, they were able to perform only 2,500 procedures. This data suggests a significant decrease in cataract procedures during the COVID-19 pandemic. However, with the increase in screen time owing to long working hours, ocular problems are one of the most reported problems worldwide and this may lead to an increase in the prevalence of optical disorders and boost the growth of the studied market during the studied period. For instance, as per a research study published in November 2021 by Jason M. Nagata et al., the average screen time of adolescents in the United States increased to 7.7 hours per day from 3.8 hours per day in pre-pandemic time and as per the same source, increase in screen time has a negative effect on the physical and mental state of the adolescent. Hence, the long-term impact of COVID-19 is expected to have a positive impact on the studied market.

The increasing burden of optical disorders such as myopia (nearsightedness), hyperopia (far-sightedness), astigmatism (distorted vision), and presbyopia, among others around the world are expected to be the major driving factor for the growth of the ophthalmic ultrasound systems market during the forecast period of the study. For instance, according to the October 2021 update of the World Health Organization (WHO), approximately 2.2 billion people around the world have near or distance vision impairment and about 1 billion of these cases of vision impairment could be prevented or are yet to be addressed. Further, as per WHO, unaddressed presbyopia is estimated to affect about 826 million people around the world. Also, as per the above-mentioned source, uncorrected refractive errors, cataracts, age-related macular degeneration, and glaucoma among others, are the major cause of vision impairment and blindness globally, and vision loss can affect people of any age but the majority is over the age of 50 years. Hence, the statements mentioned above indicate that there is a growing burden of eye diseases across the globe which is a fuelling factor for the growth of the market studied as ophthalmic ultrasound devices are used in the diagnosis of such eye diseases.

However, the increasing advancement and adoption of other diagnostic tools and rigorous government regulations are expected to hinder market growth.

Ophthalmic Ultrasound Systems Market Trends

B-Scan to Hold a Significant Share of the Market

B-Scan or Brightness Scan provides a two-dimensional cross-sectional view of the eye. It is applied on the exterior of the shut eyelid. B-scan is utilized when examining the eye ordinarily is challenging. With such advantages of a B-Scan, it is widely used globally, and companies are coming up with novel and technologically advanced B-scans, which are fuelling demand for the same. Factors such as increasing diseases coupled with the initiative by market players are expected to increase the market growth. For instance, a study published in the National Library of Medicine in February 2022 stated that the hospital admission rate for diseases of the eye and adnexa increased by 73.8% in the last two decades. Thus, high hospital admission rates increase the demand for diagnostic and surgical eye care devices, boosting the market. The above-mentioned study also reported that most people with visual impairment are elderly and fall into the age group of 50 years and above. More than 80% of people in this age group suffer from eye diseases. Therefore, the growing burden of the geriatric population is expected to increase the prevalence of eye diseases in the country and drive segmental growth. The prevalence of diabetic retinopathy is one of the key factors in market growth. The American Academy of Ophthalmology recently revealed epidemiological statistics showing that 387 million people worldwide currently suffer from diabetes mellitus, with that number expected to rise to 592 million by 2035. Worldwide, diabetic retinopathy affects 93 million individuals. Type 1 diabetes patients have a 77.3% prevalence of diabetic retinopathy, whereas type 2 diabetes patients have a 25.1% prevalence, with 25% to 30% of those patients predicted to develop vision-threatening diabetic macular edema. 5% to 8% of diabetic retinopathy patients require laser therapy. Up to 5% of individuals might need a vitrectomy operation. Ophthalmic B-mode ultrasound is used for the detection and evaluation of diabetic retinopathy complications that predict the visual outcome.

Various initiatives, such as expansion are key factors in segmental growth. In June 2022, Lumibird Medical expanded its presence in India by creating a new subsidiary in the country. The company offered various ophthalmic ultrasound products such as ABSOLU, COMPACT TOUCH, AXIALIS, etc. With such initiatives, the market is expected to grow in the country thus boosting the overall segmental growth globally.

This growing incidence rate of various eye diseases is anticipated to boost demand for B-Scan ocular ultrasound devices in the coming years.

North America Dominates the Market and is Expected to do the Same in the Forecast Period

Factors such as high disposable incomes, high awareness, the rising geriatric population, and the prevalence of eye diseases are fueling the growth of the market studied in the North American region. Various research articles published provide insight into the prevalence of blindness and other eye disorders. For instance, the article sourced in Cleveland clinic articles published in January 2022, mentioned that more than 3.4 million people in the United State aged 40 and above meet the definition of legal blindness or have corrected vision. Such increasing target disorders, which are yet to be diagnosed are also expected to drive the growth of the market. Similarly, the article published in the Ontario Association of optometrists in July 2021 mentioned that as Canada's population ages, the number of individuals living with corrected vision is growing and will impact Canada's healthcare system and economy. The report shows that 1.2 million Canadians live with the loss of vision, 466,000 in Ontario alone. The above-mentioned source also mentioned that over 8 million Canadians, nearly 3.1 million in Ontario, are living with one of the four major eye diseases (age-related macular degeneration, glaucoma, diabetic retinopathy, and cataracts) and have or are at risk of vision loss. Such increasing prevalence of eye diseases is expected to rise the demand for ophthalmic ultrasound systems for early diagnosis and drive the growth of the market.

Ophthalmic Ultrasound Systems Market Competitor Analysis

The Ophthalmic Ultrasound Systems Market is moderately fragmented. The global key players are manufacturing the majority of ophthalmic ultrasounds. Market leaders with more funds for research and a better distribution system have established their position in the market. The major players operating in the market are Appasamy Associates, DGH Technology Inc., Micro Medical Devices, NIDEK CO., LTD., Optos PLC (Nikon Corporation), Quantel Medical (Ellex Medical Lasers Ltd), Lumibird Medical (Quantel Medical), AMETEK (Reichert Inc.), and Sonomed Escalon.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Eye Diseases
    • 4.2.2 Advent of Novel Ophthalmic Technologies
    • 4.2.3 Rise in Public Health Awareness Programs by Government
  • 4.3 Market Restraints
    • 4.3.1 Increasing Advancement and Adoption of Other Diagnostic Tools
    • 4.3.2 Rigorous Government Regulations
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Product
    • 5.1.1 A- Scan
    • 5.1.2 B- Scan
    • 5.1.3 Combined Scan
    • 5.1.4 Pachymeter
    • 5.1.5 Ultrasound Bio-microscopy (UBM)
  • 5.2 By Modality
    • 5.2.1 Portable
    • 5.2.2 Standalone
  • 5.3 By End-User
    • 5.3.1 Hospitals
    • 5.3.2 Ophthalmology Clinics
    • 5.3.3 Other End-Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle-East
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle-East
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 COMPANY PROFILES
    • 6.1.1 AMETEK (Reichert Inc.)
    • 6.1.2 Appasamy Associates
    • 6.1.3 Carl Zeiss Meditec AG
    • 6.1.4 Clarion Medical Technologies
    • 6.1.5 DGH Technology Inc.
    • 6.1.6 Halma plc
    • 6.1.7 Lumibird Medical (Quantel Medical)
    • 6.1.8 MEDA Co., Ltd (Tianjin Pharmaceutical Holdings Ltd)
    • 6.1.9 Micro Medical Devices
    • 6.1.10 NIDEK CO., LTD.
    • 6.1.11 Optos PLC (Nikon Corporation)
    • 6.1.12 Sonomed Escalon

7 MARKET OPPORTUNITIES AND FUTURE TRENDS